Skip to main content

Table 1 Studies on prognosis and XRCC1 Arg194Trp and Arg399Gln polymorphisms included in the meta-analysis

From: Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis

Study

Year

Country

Ethnicity

Case No.

Stage

Outcome

SNPs

Gao et al. [24]

2006

China

Asian

57

II-IV

TR

XRCC1 Arg194Trp and Arg399Gln

Ding et al. [25]

2010

China

Asian

54

IIIB-IV

TR

XRCC1 Arg399Gln

Yuan et al. [26]

2006

China

Asian

200

advanced

TR

XRCC1 Arg194Trp

Shi et al. [27]

2006

China

Asian

112

II-IV

TR

XRCC1 Arg194Trp and Arg399Gln

Qiu et al. [28]

2009

China

Asian

107

IIIA/B-IV

TR

XRCC1 T-77C and Arg194Trp

Sun et al. [18]

2009

China

Asian

87

IV

TR

XRCC1 Arg194Trp and Arg399Gln

Song et al. [19]

2007

China

Asian

97

IIIB-IV

TR

XRCC1 Arg194Trp and Arg399Gln

Wang et al. [20]

2004

China

Asian

105

IIIB-IV

TR

XRCC1 Arg194Trp and Arg399Gln

Hong et al. [21]

2009

China

Asian

164

III-IV

TR

XRCC1 Arg194Trp and Arg399Gln

Jin et al. [22]

2006

China

Asian

162

IIIB-IV

TR

XRCC1 Arg194Trp

Qian et al. [23]

2010

China

Asian

107

IIIA/B-IV

TR

XRCC1 Arg399Gln

Cheng et al. [29]

2011

China

Asian

120

advanced

TR

XRCC1 Arg399Gln

Giachino et al. [30]

2007

Italy

Caucasian

248

IIIA/B-IV

TR/OS

XRCC1 Arg399Gln

Butkiewicz et al. [31]

2010

Poland

Caucasian

162

I, II or IIIA

OS

XRCC1 Arg399Gln

de las Penas R. et al. [32]

2006

Spain

Caucasian

135

IIIB-IV

OS

XRCC1 Arg399Gln

Yin et al. [33]

2009

China

Asian

257

I- IV

OS

XRCC1 Arg399Gln

Sreeja et al. [34]

2008

India

Caucasian

211

I- IV

OS

XRCC1 Arg399Gln

Gurubhagavatula et al. [35]

2004

USA

Caucasian

103

IIIA/B-IV

OS

XRCC1 Arg399Gln

Kalikaki et al. [36]

2009

Greece

Caucasian

119

IIIA/B-IV

TR/OS

XRCC1 Arg399Gln

Liu et al. [37]

2008

China

Asian

53

I- IV

OS/PFS

XRCC1 Arg399Gln

Han et al. [38]

2011

Korea

Asian

158

IIIB-IV

OS/PFS

XRCC1 Arg399Gln

Yao et al. [39]

2009

China

Asian

108

IIIA/B-IV

OS

XRCC1 Arg399Gln

  1. TR: objective response
  2. OS: overall survival
  3. PFS: progression-free survival